Martin S. Rash
Chairman of the Board of Directors

Mr. Rash is Chairman and CEO of RegionalCare Hospital Partners, Inc., a hospital company that he recently founded and for which he raised $300 million of equity from New York-based Warburg Pincus.  Previously, he was Chairman and CEO of Province Healthcare Company, which he founded as a start-up in 1996 backed by Chicago-based GTCR. Under his direction, Province completed a successful IPO in 1998 and grew to 21 hospitals across the U.S. with revenues of nearly $1 billion by 2004 when it was sold to Lifepoint Hospitals, Inc. (NASDAQ: LPNT) for $1.7 billion. Previously, Mr. Rash was Executive Vice President and COO at Community Health Systems, Inc. (NYSE: CYH).  Mr. Rash was an early investor in Odyssey Healthcare, one of the largest hospice companies in the U.S. and is currently a board member of HealthSpring, Inc. (NYSE: HS). Mr. Rash was also past Chairman of the Federation of American Hospitals and the Nashville Health Care Council. Mr. Rash holds a bachelors degree and an MBA from Middle Tennessee State University. Back

Mr. Linehan is a General Partner at New Enterprise Associates (NEA).  He joined NEA in 1992 as an Associate, became a Partner in 1997, and a General Partner in 2004. Mr. Linehan specializes in healthcare investments, including healthcare services, healthcare IT and later stage medical products companies. He participated in the founding and incubation of Bravo Health. Current board memberships include American Pathology Partners, Bravo Health, Elance, Elements Behavioral Health, Simplex Diabetic Supply, Ulthera and Vantage Oncology. His prior board memberships include, among others, CHG Healthcare Services, Atomz, Long Term Care Group and ppoNEXT. In the past, Mr. Linehan has also worked closely with AMERIGROUP, AMISYS, Informative and Scandipharm. Mr. Linehan received a BA (cum laude) from Harvard University. Back

Mohamad Makhzoumi
Board Member

Mr. Makhzoumi is a Principal at New Enterprise Associates (NEA).  He joined NEA in 2005 with a focus on investments primarily in the healthcare services and healthcare information technology arenas. He has been involved with NEA’s investments in American Pathology Partners, Bariatric Partners, Bravo Health, CHG Healthcare Services, Simplex Diabetic Supply and Subacute Holdings. Prior to joining NEA, Mr. Makhzoumi was most recently an Associate with Summit Partners, where he was one of fifty professionals responsible for investing and managing over $5.5 billion in capital. Mr. Makhzoumi focused on growth equity investments ranging from $15 – $300 million, including Summit’s investment in Global Cash Access (NYSE: GCA). Previously, Mr. Makhzoumi worked with UBS Investment Bank where he was a member of the inaugural class for the UBS Los Angeles office as an investment banker in the leveraged finance group. Mr. Makhzoumi also spent a summer as an analyst with the NEA healthcare team, focusing on investments in healthcare services, healthcare information technology, and medical devices. He received a bachelor's degree, with distinction, in International Relations from the University of Pennsylvania. Back

Richard Whitney
Board Member

Mr. Whitney currently serves as Chief Financial Officer of DaVita, Inc. (NYSE: DVA), the largest operator of kidney dialysis centers in the U.S. with over 1,300 outpatient dialysis facilities.  He is also a Venture Partner at New Enterprise Associates (NEA) which he joined 2007 focusing on healthcare investments. Prior to that, he was the founder and Managing Member of Whitney Capital LLC, a private equity investment firm focused primarily on healthcare services and products. Previously, Mr. Whitney served as Executive Chairman of Specialty Labs where he led the turnaround and successful sale of the company. Earlier, he served as Chief Financial Officer of DaVita, Inc. where he was a lead executive in the company’s financial and operating turnaround which created over $3 billion of equity value for investors. Mr. Whitney earned an MBA from Harvard Business School and a BS in Business Administration from Pennsylvania State University. Back

Robert A. Yeager
Chief Executive Officer
Board Member

Mr. Yeager is the CEO of American Pathology Partners.  Prior to APP, he was Chairman of Attentus Healthcare Company, an operator of rural acute care hospitals, which he co-founded. Previously, he was President and CEO of OrthoLink Physicians Corporation, one of the largest providers of physician management services for orthopedic and sports-medicine doctors, that was backed by Welsh Carson. The company provided services for over 200 physicians across the country. Prior to OrthoLink, Mr. Yeager was Executive Vice President and CFO of Quorum Health Group, a large hospital management company founded as a spin-off of HCA and backed by Welsh Carson. At Quorum, Mr. Yeager completed a $115 million IPO and raised over $200 million of debt capital. Previously, he held several positions with Hospital Corporation of America (HCA) and Management Company which ultimately was spun off to form Quorum. Mr. Yeager is a CPA (inactive) and holds a BBA from Middle Tennessee State University. Back